Dr. Camille Ettelaie, Biomedical Section, Department of Biological Sciences, University of Hull, Cottingham Road, Hull, HU6 7RX, UK, Tel.: +44 1482 465528, Fax: +44 1482 465458, E-mail:
Thromb Haemost. 2013 Nov;110(5):966-76. doi: 10.1160/TH13-01-0055. Epub 2013 Aug 15.
In this study the uptake of tissue factor (TF)-positive microparticles by endothelial cells and the recycling of the TF component were examined. Human dermal blood endothelial cells (HDBEC) were incubated with microparticles derived from cancer cell lines for up to 6 hours. Measurement of HDBEC cell surface TF antigen revealed two distinct peaks at 30 and 180-240 minutes post-incubation with TF-positive, but not TF-deficient microparticles. However, only the second peak was concurrent with high TF activity as determined by a chromogenic thrombin-generation assay. Annexin V-labelling of HDBEC showed phosphatidylserine exposure following 90 minutes incubation with microparticles, which explains the high TF activity associated with the second antigen peak. Analysis of TF mRNA levels revealed no de novo expression of TF mRNA in response to microparticles, and pre-incubation of cells with cycloheximide did not prevent the appearance of TF. However, blocking endocytosis with a dynamin inhibitor prolonged the disappearance and prevented the reappearance of TF antigen on the cell surface. Incubation of HDBEC with microparticles containing TF-GFP revealed the early co-localisation of TF with Rab4 and Rab5, followed by co-localisation with the late endosomal/trans-Golgi network marker Rab9, and the recycling endosome marker Rab11. siRNA-mediated suppression of Rab11 reduced the reappearance of TF on the cell surface. These data suggest a mechanism by which TF-containing microparticles are internalised by endothelial cells and the TF moiety recycled to the cell surface. Together with the exposure of phosphatidylserine, this is capable of inducing a substantial increase in the procoagulant potential of the surface of endothelial cells.
在这项研究中,研究了组织因子 (TF)-阳性微粒体被内皮细胞摄取和 TF 成分的再循环。将人真皮血管内皮细胞 (HDBEC) 与源自癌细胞系的微粒体孵育长达 6 小时。测量 HDBEC 细胞表面 TF 抗原显示,在用 TF 阳性但不是 TF 缺陷的微粒体孵育 30 和 180-240 分钟后出现两个明显的峰。然而,只有第二个峰与高 TF 活性同时出现,这是通过显色法凝血酶生成测定确定的。HDBEC 的 Annexin V 标记显示,在用微粒体孵育 90 分钟后暴露了磷脂酰丝氨酸,这解释了与第二个抗原峰相关的高 TF 活性。TF mRNA 水平的分析显示,微粒体没有引起 TF mRNA 的新表达,并且细胞的预孵育用环己酰亚胺不能阻止 TF 的出现。然而,用一种胞吞作用抑制剂阻断内吞作用会延长 TF 抗原在细胞表面上的消失时间,并防止其重新出现。用含有 TF-GFP 的微粒体孵育 HDBEC 显示 TF 与 Rab4 和 Rab5 的早期共定位,随后与晚期内体/反高尔基网络标记物 Rab9 共定位,以及再循环内体标记物 Rab11 共定位。siRNA 介导的 Rab11 抑制减少了 TF 在细胞表面上的重新出现。这些数据表明了一种机制,即含有 TF 的微粒体被内皮细胞内吞,并且 TF 部分被再循环到细胞表面。与磷脂酰丝氨酸的暴露一起,这能够诱导内皮细胞表面促凝潜能的显著增加。